A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects
Clinical trial NCT05380427 · COMPLETED
Trial details
- NCT number
- NCT05380427
- Sponsor
- Cutia Therapeutics（Wuxi）Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-15
- Primary completion
- 2023-11-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.